ESC 365 - Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator

EHRA Premium Access

Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator

Session: Arrhythmias 12: atrial fibrillation

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor M. Zylla (Heidelberg, DE)

Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Maura Magdalena Zylla

University Hospital Heidelberg, Heidelberg (Germany)

0 follower

8 more presentations in this session

Staged hybrid convergent procedure versus pulsed field ablation for pulmonary veins and posterior wall isolation in the treatment of atrial fibrillation

Speaker: Doctor E. Zito (Milan, IT)

Feasibility and determinants of short-term heart rate variability in patients using photoplethysmography-based wearable devices - data derived from TeleCheck-AF

Speaker: Doctor H. Hillmann (Hannover, DE)

Exploration of peak frequency mapping for ventricular tachycardia ablation. Identification of critical isthmus zones during substrate mapping

Speaker: Mr J. Mayer (Stoke-on-Trent, GB)

Electrocardiographic characteristics and catheter ablation of premature ventricular complex- mediated ventricular fibrillation

Speaker: Doctor A. Maan (New York, US)

Preliminary implantation experience in Europe with a novel insertable cardiac monitor

Speaker: Doctor S. Fareh (Lyon, FR)

Access the full session

Arrhythmias 12: atrial fibrillation

Speakers: Doctor M. Zylla, Doctor E. Zito, Doctor H. Hillmann, Mr J. Mayer, Doctor A. Maan...

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources